Skip to main content
. 2016 Mar 7;95(9):e2702. doi: 10.1097/MD.0000000000002702

FIGURE 4.

FIGURE 4

Changes in PROs in Asian patients by post-treatment week 12 with sofosbuvir-containing regimens (SVR-12 only). The PROs are normalized to a 0%–100% scale. Average across all 26 PROs: +1.2% (min −5.7%, max +8.8%) in RBV ± IFN (+SOF); +3.4% (min −13.1%, max +13.0%) in LDV/SOF.